Prognostic factors and survival in primary rectal adenocarcinoma;Fatores prognósticos e sobrevida no adenocarcinoma primário de reto

Revista Brasileira de Coloproctologia

Volumn 28, Issue 1, 2008, Pages 62-71

  Guedes Müssnich, Heloisa ^a,b   Moreira, Luis Fernando ^a   Gus, Pedro ^a   Pimentel, Marcelo ^a   Simon, Tatiana ^a   Bello Dos Santos, Marcelo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UFRGS ^*  (Brazil)

Author keywords

Histopathological staging; Prognostic factors; Rectal adenocarcinoma; Recurrence; Survival

Indexed keywords

EID: 44649175328     PISSN: 01019880     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0101-98802008000100009     Document Type: Article

References (41)

1. Ky AJ, Sung MW, Milsom JW. Research in colon and rectal cancer, with an emphasis on surgical progress. Dis Colon Rectum 1999; 42(11): 1369-1380.
2. Williams NS. Colorectal cancer: epidemiology, aetiology, pathology, clinical features and diagnosis. In: Keighley MR, Williams NS, eds. Surgery of the anus, rectum and colon. London: WB Saunders; 1993. p. 830-885.
3. Santos JCM Jr. Tratamento coadjuvante do câncer do reto: I - Radioterapia pré-operatória. Rev Bras Coloproct 1997; 17(1): 69-73.
4. Wilmink AB. Overview of the epidemiology of colorectal cancer. Dis Colon Rectum 1997; 40(4): 483-493.
5. European School of Oncology. Task Force Preview, Geneva, Switzerland. Issue 2, Sept 1997.
6. Brasil, Ministério da Saúde, Instituto Nacional do Câncer, Coordenadoria de Programas de Controle do Câncer. O problema do câncer no Brasil. 4' ed. Rio de Janeiro: INCa/ Pro-Onco; 1997.
7. Pinho MSL, Ferreira LC, Kleinubing Jr. H. Tratamento cirúrgico do câncer colorretal: resultados a longo prazo e análise da qualidade. Rev Bras Coloproct 2006; 26(4): 422-429.
8. National Cancer Institute, PDQ. Rectal Cancer. 2007; 1-27. Available: http://www.cancer.gov
9. Pinho MSL. Marcadores moleculares como fatores prognósticos do câncer colorretal. Rev Bras Coloproct 1999; 19 (2): 130-132.
10. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341(8843): 457-460.
11. Macdonald JS. Adjuvant therapy of colon cancer. CA Cancer J Clin 1999; 49(4): 202-219.
12. Department of pathology, SGPGIMS. Prognostic factors predicting outcome in colorectal cancers. On-line seminars and tutorials. Lucknow, India. 2007; 1-6. Available: http://www.sgpgi.ac.in/path/seminars.
13. Rosito MA, Müssnich JFX, Gus PG, Weindorfer M, Schaefer LG, Pinheiro PM. Amputação abdomino-perineal em adenocarcinoma de reto. II levantamento do HCPA. Rev AMRIGS 1995; 39:200-204.
14. Dias GB, Bauermann FB, Linhares EL, Mercado C, Moreira LF. Estudo retrospectivo do indice de mortalidade por câncer de cólon e de reto ern Porto Alegre e no Rio Grande do Sul. Proc XV JACAD 1997; 15: TL038-29.
15. Gordon PH. Malignant neoplasms of the colon. In: Gordon PH, Nivatvongs S, eds. Principles and practice of surgery for the colon, rectum and anus. St. Louis: Quality Medical; 1992. p. 501-565.
16. Norstein J, Langmark F. Results of rectal cancer treatment: a national experience. In: Søreide O, Norstein J, eds. Rectal cancer surgery. Optimisation - Standardisation - Documentation. Oslo: Springer; 1997. p. 17-28.
17. Ratto C, Sofo L, Ippoliti M, Merico M, Doglietto GB, Crucitti F. Prognostic factors in colorectal cancer: literature review for clinical application. Dis Colon Rectum 1998; 41(8): 1033-1049.
18. Rawet V. Carcinoma colorretal: estadiamento e parâmetros prognósticos [tese]. São Paulo: Universidade de São Paulo; 1998.
19. Bokey EL, Chapuis PH, Dent OF, Newland RC, Koorey SG, Zelas PJ, et al. Factors affecting survival after excision of the rectum for cancer: a multivariate analysis. Dis Colon Rectum 1991; 40(1): 3-10.
20. Nan KJ, Qin HX, Yang G. Prognostic factors in 165 elderly colorectal cancer patients. World J Gastroenterol. 2003; 9(10): 2207-2210.
21. Jessup JM, Menck HR, Fremgen A, Winchester DP. Diagnosing colorectal carcinoma: clinical and molecular approaches. CA Cancer J Clin 1997; 47(2): 70-92,
22. Carneiro Neto JD, Barreto JBP, Freitas NS, Queiroz MA. Câncer colorretal: características clinicas e anatomopatológicas em pacientes corn idade inferior a 40 anos. Rev Bras Coloproct, 2006; 26(4): 430-435.
23. Monteiro EP, Salem JB, Taglietti EM, Albuquerque IC, Formiga GJS. Neoplasia colorretal até 40 anos - experiência em cinco anos. Rev Bras Coloproct. 2006; 26(2):156-161.
24. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. Arch Pathol Lab Med. 2000; 124(7): 979-994.
25. Wood CB, Gillis CR, Hole D, Malcolm AJ, Blumgart LH. Local tumour invasion as a prognostic factor in colorectal cancer. Br J Surg. 1981; 68(5): 326-328.
26. Santos JCM Jr. Tratamento coadjuvante do câncer do reto: II - Quimioterapia. Rev Bras Coloproct 1997; 17(2): 143-149.
27. Hermanek P. Impact of surgeon's technique on outcome after treatment of rectal carcinoma. Dis Colon Rectum 1999; 42(5): 559-562.
28. Moriya Y, Hojo Y, Sawada. T, Koyama Y. Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 1989; 32(4): 307-315.
29. Moreira LF, Hizuta H, Iwagaki H, Tanaka N, Orita K. Lateral lymph node dissection for rectal carcinoma below the peritoneal reflection. Br J Surg 1994; 81(2): 293-296.
30. Heald RJ, Smedh RK, Kald A, Sexton R, Moran BJ. Abdominoperineal excision of the rectum - an endangered operation. Norman Nigro Lectureship. Dis Colon Rectum 1997; 40(7): 747-751.
31. Reis Neto JA, Cordeiro F, Reis JA Jr, Kagohara O, Simões Neto J. Laparoscopic total mesorectum excision. In: Reis Neto JA, ed. New trends in coloproctology. Campinas: Revinter; 2000. p. 497-504.
32. Habr-Gama A, Souza PM, Ribeiro U Jr., Campos F, Sousa AH Jr., Nadalin W, Gansl R, et al. Low rectal cancer: impact of pre-operative radiation and chemotherapy on surgical treatment. "Hospital das Clinicas" of the University of São Paulo Medical School experience. In: Reis Neto JA, ed. New trends in coloproctology. Campinas: Revinter; 2000. p. 423-429.
33. Bozzetti F, Bertario L, Rossetti C, Gennari L, Andreola S, Baratti D, et al. Surgical treatment of locally recurrent rectal carcinoma. Dis Colon Rectum 1997; 40(12): 1421-1424.
34. Søreide O, Norstein J, Fielding P, Silen W, International standardization and documentation of the treatment of rectal cancer. In: Søreide O, Norstein J, eds. Rectal cancer surgery. Optimisation - Standardisation - Documentation. Oslo: Springer; 1997. p. 405-446.
35. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP. American Joint Committee on Cancer Prognostic factors consensus conference: Colorectal Working Group. Cancer 2000; 88(7): 1739-1757.
36. Kim JC, Han MS, Lee HK, Kim WS, Park SK, Park KC, et al. Distribution of carcinoembryonic antigen and biologic behavior in colorectal carcinoma. Dis Colon Rectum 1999; 42(5):640-648.
37. Mulcahy BE, Toner M, Patchett SE, Daly L, O'Donoghue DP. Identifying stage B colorectal cancer patients at high risk of tumor recurrence and death. Dis Colon Rectum 1997; 40(3): 326-331.
38. Reis Neto JA, Quilici FA, Cordeiro F, Ciquini S, Reis JA Jr. Pre-operative radiotherapy in rectal cancer: evaluation of irradiation effects on cellular undifferentiation and its influence on prognosis. Hepatogastroenterology 1999; 46(29): 2825-2830.
39. Jucá MJ, Matos D, D'Ippolito G. Estudo da validação do exame digital do reto no estadiamento clínico pré-operatório dos adenocarcinomas tocáveis de reto. Rev Bras Coloproct 1999; 19(4):248-258.
40. Chok KS, Law WL. Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg. 2007; 31(7): 1485-90. Epub 2007 May 18.
41. Hetnal M, Malecki K, Korzeniowski S, Zemelka T. Postoperative chemoradiotherapy in patients with rectal cancer, prognostic factors for disease control and survival. J Clin Oncol. 2006; 24(18S): 13575.